Rho-associated coiled-coil-forming kinases (ROCKs): Potential targets for the treatment of atherosclerosis and vascular disease

Trends in Pharmacological Sciences

Volumn 32, Issue 3, 2011, Pages 167-173

  Zhou, Qian ^a,b   Gensch, Christoph ^a   Liao, James K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; APOLIPOPROTEIN E; CASPASE 3; COFILIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EZRIN; FASUDIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIM KINASE; MOESIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; RADIXIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHO KINASE INHIBITOR; SAR 407899; SERINE PROTEINASE INHIBITOR; SLX 2119; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ADIPOGENESIS; AMINO ACID SEQUENCE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL POLARITY; CELL PROLIFERATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; HUMAN; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; REVIEW; VASCULAR DISEASE;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PROTEIN KINASE INHIBITORS; RHO-ASSOCIATED KINASES; VASCULAR DISEASES;

EID: 79952455313     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2010.12.006     Document Type: Review

References (75)

1. T. Leung The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton Mol. Cell. Biol. 16 1996 5313 5327 (Pubitemid 26315050)
2. A.P. Somlyo, and A.V. Somlyo Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II J. Physiol. 522 2000 177 185 (Pubitemid 30068498)
3. H. Shimokawa, and A. Takeshita Rho-kinase is an important therapeutic target in cardiovascular medicine Arterioscler. Thromb. Vasc. Biol. 25 2005 1767 1775 (Pubitemid 41243442)
4. H. Shimokawa, and M. Rashid Development of Rho-kinase inhibitors for cardiovascular medicine Trends Pharmacol. Sci. 28 2007 296 302 (Pubitemid 46818464)
5. Q. Zhou, and J.K. Liao Pleiotropic effects of statins - basic research and clinical perspectives Circ. J. 74 2010 818 826
6. Q. Zhou, and J.K. Liao Rho kinase: an important mediator of atherosclerosis and vascular disease Curr. Pharm. Des. 15 2009 3108 3115
7. A.B. Jaffe, and A. Hall Rho GTPases: biochemistry and biology Annu. Rev. Cell Dev. Biol. 21 2005 247 269 (Pubitemid 41740635)
8. T. Leung A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes J. Biol. Chem. 270 1995 29051 29054
9. T. Matsui Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho EMBO J. 15 1996 2208 2216 (Pubitemid 26141137)
10. T. Ishizaki The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase EMBO J. 15 1996 1885 1893 (Pubitemid 26119224)
11. K. Riento, and A.J. Ridley Rocks: multifunctional kinases in cell behaviour Nat. Rev. Mol. Cell Biol. 4 2003 446 456 (Pubitemid 36648590)
12. R. Rikitake, and J.K. Liao ROCKs as therapeutic targets in cardiovascular diseases Expert Rev. Cardiovasc. Ther. 3 2005 441 451 (Pubitemid 40691914)
13. M. Amano The COOH terminus of Rho-kinase negatively regulates rho-kinase activity J. Biol. Chem. 274 1999 32418 32424
14. J. Feng Rho-associated kinase of chicken gizzard smooth muscle J. Biol. Chem. 274 1999 3744 3752 (Pubitemid 29077222)
15. M. Sebbagh Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing Nat. Cell Biol. 3 2001 346 352 (Pubitemid 32288441)
16. M.L. Coleman Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I Nat. Cell Biol. 3 2001 339 345 (Pubitemid 32288440)
17. M. Sebbagh Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner J. Exp. Med. 201 2005 465 471 (Pubitemid 40229420)
18. X.Q. Chen Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies J. Biol. Chem. 277 2002 12680 12688
19. Y. Ward The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway J. Cell Biol. 157 2002 291 302 (Pubitemid 34839825)
20. H. Yamaguchi Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil Structure 14 2006 589 600 (Pubitemid 43363491)
21. V. Chevrier The Rho-associated protein kinase p160ROCK is required for centrosome positioning J. Cell Biol. 157 2002 807 817 (Pubitemid 34847818)
22. R. Fox PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages EMBO J. 26 2007 505 515 (Pubitemid 46160950)
23. A. Yoneda The Rho kinases I and II regulate different aspects of myosin II activity J. Cell Biol. 170 2005 443 453 (Pubitemid 41126943)
24. M. Amano Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity Cytoskeleton (Hoboken) 67 2010 545 554
25. T. Sumi Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase J. Biol. Chem. 276 2001 670 676 (Pubitemid 32050364)
26. M. Amano Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) J. Biol. Chem. 271 1996 20246 20249 (Pubitemid 26281788)
27. G. Velasco Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1 M at Thr850 induces its dissociation from myosin FEBS Lett. 527 2002 101 104 (Pubitemid 35253847)
28. K. Ohashi Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop J. Biol. Chem. 275 2000 3577 3582 (Pubitemid 30083067)
29. M. Maekawa Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase Science 285 1999 895 898 (Pubitemid 29381991)
30. M.J. Hart Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13 Science 280 1998 2112 2114 (Pubitemid 28366203)
31. T. Kozasa p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13 Science 280 1998 2109 2111 (Pubitemid 28366202)
32. M. Uehata Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension Nature 389 1997 990 994 (Pubitemid 27485693)
33. B. Wojciak-Stothard, and A.J. Ridley Rho GTPases and the regulation of endothelial permeability Vasc. Pharmacol. 39 2002 187 199 (Pubitemid 37492962)
34. N. Begum Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells J. Biol. Chem. 277 2002 6214 6222 (Pubitemid 34968412)
35. R. Sordella Modulation of CREB activity by the Rho GTPase regulates cell and organism size during mouse embryonic development Dev. Cell 2 2002 553 565 (Pubitemid 34538137)
36. R. Sordella Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis Cell 113 2003 147 158 (Pubitemid 36514967)
37. Q. Zhou, and J.K. Liao Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy Curr. Pharm. Des. 15 2009 467 478
38. U. Laufs, and J.K. Liao Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J. Biol. Chem. 273 1998 24266 24271 (Pubitemid 28435775)
39. C.D. Searles Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth Circ. Res. 95 2004 488 495 (Pubitemid 39180929)
40. S. Wolfrum Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection Arterioscler. Thromb. Vasc. Biol. 24 2004 1842 1847 (Pubitemid 39350301)
41. A. Masumoto Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina Circulation 105 2002 1545 1547 (Pubitemid 34297629)
42. G.J. Pyne-Geithman PKC and Rho in vascular smooth muscle: activation by BOXes and SAH CSF Front. Biosci. 13 2008 1526 1534 (Pubitemid 351594723)
43. M. Dong Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm Cardiovasc. Hematol. Agents Med. Chem. 7 2009 322 330
44. C.M. Alvira Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cells Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L872 878
45. K. Abe Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats Circ. Res. 94 2004 385 393 (Pubitemid 38240731)
46. K. Ito Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition Hypertension 43 2004 156 162 (Pubitemid 38174167)
47. Y. Rikitake Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection Stroke 36 2005 2251 2257 (Pubitemid 41429255)
48. R. Shibata Rho-kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis J. Cardiovasc. Pharmacol. 42 Suppl. 1 2003 S43 47
49. W. Bao Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury Cardiovasc. Res. 61 2004 548 558 (Pubitemid 38210160)
50. Z. Mallat Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice Circ. Res. 93 2003 884 888 (Pubitemid 37363063)
51. -/- mice FASEB J. 22 2008 3561 3570
52. T. Hattori Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice Circ. Res. 94 2004 46 52 (Pubitemid 38064097)
53. J. Hiroki Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells J. Mol. Cell. Cardiol. 37 2004 537 546 (Pubitemid 38953381)
54. K. Buyukafsar Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide- treated rats Eur. J. Pharmacol. 498 2004 211 217 (Pubitemid 39208081)
55. P. Libby Inflammation and atherosclerosis Circulation 105 2002 1135 1143 (Pubitemid 34212626)
56. P. Aukrust Chemokines and cardiovascular risk Arterioscler. Thromb. Vasc. Biol. 28 2008 1909 1919
57. G.P. van Nieuw Amerongen Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction Arterioscler. Thromb. Vasc. Biol. 20 2000 E127 133
58. H. Shimokawa Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo Cardiovasc. Res. 51 2001 169 177 (Pubitemid 32523066)
59. M. Rekhter Immunohistochemical analysis of target proteins of Rho-kinase in a mouse model of accelerated atherosclerosis Exp. Clin. Cardiol. 12 2007 169 174
60. T. Hidaka Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers Hypertens. Res. 33 2010 354 359
61. P.Y. Liu Increased Rho kinase activity in a Taiwanese population with metabolic syndrome J. Am. Coll. Cardiol. 49 2007 1619 1624
62. A. Nohria Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease Circ. Res. 99 2006 1426 1432 (Pubitemid 44949679)
63. U. Forstermann, and T. Munzel Endothelial nitric oxide synthase in vascular disease: from marvel to menace Circulation 113 2006 1708 1714
64. Y. Suzuki Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study Neurol. Med. Chir. (Tokyo) 48 2008 241 247 (Pubitemid 351883939)
65. S. Shirao Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway Cerebrovasc. Dis. 26 2008 30 37 (Pubitemid 351931418)
66. Y. Rikitake, and J.K. Liao Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells Circulation 111 2005 3261 3268 (Pubitemid 40874999)
67. R. Kishore The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A J. Clin. Invest. 115 2005 1785 1796 (Pubitemid 40979717)
68. M. Shibuya Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial J. Neurol. Sci. 238 2005 31 39 (Pubitemid 41560951)
69. T.J. Bivalacqua RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction Proc. Natl. Acad. Sci. U.S.A. 101 2004 9121 9126 (Pubitemid 38781621)
70. B.K. Mueller Rho kinase, a promising drug target for neurological disorders Nat. Rev. Drug Discov. 4 2005 387 398 (Pubitemid 40704122)
71. G. Loirand, and P. Pacaud The role of Rho protein signaling in hypertension Nat. Rev. Cardiol. 7 2010 637 647
72. H. Fujita Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension Heart Vessels 25 2010 144 149
73. H. Shimokawa Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study J. Cardiovasc. Pharmacol. 40 2002 751 761 (Pubitemid 36109293)
74. T. Kishi Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure Circulation 111 2005 2741 2747 (Pubitemid 40791544)
75. M. Lohn Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor Hypertension 54 2009 676 683